glp-1 weight loss drug news today drugs leave users low on key nutrients, study finds With FDA approval of Wegovy
Description
key role of GLP-1R
October 2, 2023
Theyll likely suggest starting the new medication at a low dose but the approach may be different for everyone depending on factors such as your current dosage, how long youve been taking the medication, and why youre switching in the first place
In metabolic dysfunctionassociated steatohepatitis (MASH), for example, it remains uncertain whether improvements in hepatic inflammation and fibrosis are exclusively secondary to weight loss and metabolic improvements, or whether direct hepatoprotective mechanisms are involved
Take it any time
Foreman KJ, Marquez N, Dolgert A, et al
